![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 08 July 2024
Sec. Translational and Clinical Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1448887
This article is a correction to:
Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations
By Jasuja GK, Wolfe HL, Reisman JI, Vimalananda VG, Rao SR, Blosnich JR, Livingston NA and Shipherd JC (2024). Front. Endocrinol. 15:1086158. doi: 10.3389/fendo.2024.1086158
In the published article, there was an error. A sentence in the results sub-section of the abstract did not match with a sentence in the results section 3.3 “Guideline concordance on GAHT initiation” on page 5 of the published article.
A correction has been made to the Results section in the Abstract. This sentence previously stated: “Among veterans who started feminizing GAHT with estrogen, 97.0% were guideline concordant due to no documentation of venous thromboembolism, breast cancer, stroke, or myocardial infarction.”
The corrected sentence appears below.
“Among veterans who started feminizing GAHT with estrogen, 98.6% were guideline concordant due to no documentation of venous thromboembolism, or breast cancer.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gender-affirming hormone therapy, clinical guidelines, guideline concordance, transgender and gender diverse, veterans, Veterans Health Administration
Citation: Jasuja GK, Wolfe HL, Reisman JI, Vimalananda VG, Rao SR, Blosnich JR, Livingston NA and Shipherd JC (2024) Corrigendum: Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations. Front. Endocrinol. 15:1448887. doi: 10.3389/fendo.2024.1448887
Received: 14 June 2024; Accepted: 28 June 2024;
Published: 08 July 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Jasuja, Wolfe, Reisman, Vimalananda, Rao, Blosnich, Livingston and Shipherd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guneet K. Jasuja, Z3VuZWV0a0BidS5lZHU=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.